The research interest of Pierre Maisonneuve is to decipher the molecular mechanisms of protein pseudokinases in human signaling. Pseudokinase proteins are crucial regulators of cell signaling and their dysregulation are implicated in many human diseases, such as cancer. Therefore, they are very promising therapeutic targets. However, much remains to be learned about the mechanism by which they regulate cell signaling and affect biological processes. To this aim, his group combines state-of-the-art structural biology (Cryo-EM, X-Ray crystallography and NMR), functional characterization of proteins and development of new chemical tools, which can serve as proof-of-concept for new therapeutical acvenues.
2023: CNRS Research tenure position (CBMN UMR5248)
2022: Group leader IECB - Bordeaux (France)
2015-2022: Post-doc - Dr. Sicheri lab - LTRI - Toronto (Canada)
2014: PhD in Structural biology - Dr. Wolff lab - Institut Pasteur - Paris (France)
Lavoie Hugo, Jin Ting, Lajoie Driss, Decossas Marion, Gendron Patrick, Wang Bing, Filandr Frantisek, Sahmi Malha, Hwa Jo Chang, Weber Sandra, Arseneault Geneviève, Tripathy Sasmita, Beaulieu Pierre, Schuetz Doris, Schriemer David, Marinier Anne, Rice William, Maisonneuve Pierre, Therrien Marc